Dr. Chinnaiyan's laboratory has focused on functional genomic, proteomic, and bioinformatics approaches to study cancer for the purposes of understanding cancer biology as well as to discover clinical biomarkers. He and his collaborators have characterized a number of biomarkers of prostate cancer including AMACR, EZH2, and hepsin. AMACRis being used clinically across the country in the assessment of cancer in prostate needle biopsies.
Arul Chinnaiyan, MD, Ph.D.
Michigan Center for Translational Pathology